Filing Flows › Rapid Micro Biosystems (RPID) › Q2 2026 › vs Q1 2026
Rapid Micro Biosystems (RPID) Q2 2026 vs Q1 2026 (quarter over quarter)
Rapid Micro Biosystems's revenue rose $52K (+0.6%) from $8.0M in Q1 2026 to $8.1M in Q2 2026. The biggest changes: Service +$344K (+14%); Product −$292K (-5%).
Rapid Micro Biosystems, Q2 2026: revenue $8.1M (+11% year over year), operating margin -153.0%, net loss $12.9M, operating cash flow −$12.7M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product | $5.3M | $5.6M | −$292K | -5% |
| Service | $2.8M | $2.4M | $344K | +14% |
| Revenue | $8.1M | $8.0M | $52K | +0.6% |
| Net loss | $12.9M | $14.3M | −$1.4M | -9% |
| Costs & expenses | $21.0M | $22.3M | −$1.3M | -6% |
| Operating costs | $20.4M | $21.9M | −$1.5M | -7% |
| Interest & other, net | $556K | $415K | $141K | +34% |
| Income tax | $45K | $8K | $37K | +462% |
| Cost of revenue | $6.8M | $7.6M | −$789K | -10% |
| Research & development | $3.3M | $3.4M | −$27K | -0.8% |
| Sales & marketing | $3.4M | $3.4M | $14K | +0.4% |
| General & admin | $6.8M | $7.4M | −$676K | -9% |
| Operating cash sources | $14.7M | $17.0M | −$2.3M | -13% |
| Depreciation & amortization | $674K | $706K | −$32K | -5% |
| Share-based compensation | $1.3M | $1.2M | $98K | +8% |
| Cash used in operations | $12.7M | $15.1M | −$2.4M | -16% |
| Net loss absorbed | $12.9M | $14.3M | −$1.4M | -9% |
| Working capital & other | $1.8M | $2.7M | −$938K | -35% |
Questions
How much did Rapid Micro Biosystems's revenue grow quarter over quarter in Q2 2026?
Rapid Micro Biosystems's revenue rose $52K (+0.6%) from $8.0M in Q1 2026 to $8.1M in Q2 2026.
What drove Rapid Micro Biosystems's revenue change in Q2 2026?
Service +$344K (+14%); Product −$292K (-5%).